Refresher Course: Oncologic Imaging
RC 1416 - Oligometastatic disease: a need for standardisation
Lectures
1
Chairperson's introduction
03:00Wolfgang Gerhard Kunz, Munich / DE
2
The EORTC-ESTRO classification of oligometastatic disease
16:00Matthias Guckenberger, Zurich / CH
3
The impact of imaging modality and definition of oligometastatic disease
16:00Clarisse Dromain, Lausanne / CH
4
Current evidence of benefit in metastasis-directed radiotherapy
16:00Joost JC Verhoeff, Amsterdam / NL
5
Panel discussion: Is it time for modified definitions of oligometastaticdisease for specific cancer entities?
09:00Panel discussion: Is it time for modified definitions of oligometastaticdisease for specific cancer entities?
3 min
Chairperson's introduction
Wolfgang Gerhard Kunz, Munich / Germany
16 min
The EORTC-ESTRO classification of oligometastatic disease
Matthias Guckenberger, Zurich / Switzerland
- To understand the clinical background and history of oligometastatic disease.
- To learn about the EORTC-ESTRO classification of oligometastatic disease.
- To know how structured classifications improve communication in tumour boards.
16 min
The impact of imaging modality and definition of oligometastatic disease
Clarisse Dromain, Lausanne / Switzerland
- To understand how imaging accuracy affects the definition of oligometastasis.
- To learn about tumour-specific imaging approaches for suspected oligometastasis.
- To know how modern diagnostic imaging exams may lead to stage migration.
16 min
Current evidence of benefit in metastasis-directed radiotherapy
Joost JC Verhoeff, Amsterdam / Netherlands
- To understand how radiation therapy is used to treat oligometastatic cancers.
- To learn about challenges for and limitations of metastasis-directed radiotherapy.
- To know how radiology can contribute to radiation treatment planning.
9 min
Panel discussion: Is it time for modified definitions of oligometastaticdisease for specific cancer entities?